Get More Info On: Michigan Stated Income Loans | Michigan No Doc Mortgage | Michigan Asset Based Lender | Michigan Private Loans
in the Following Areas:: Detroit, Grand Rapids, Warren, Sterling Heights, Lansing, Ann Arbor, Flint, Dearborn, Livonia, Clinton Township
Today's Date: 2014-11-25
StatedMortgageLoans.com

Michigan | Stated Income Loans | No Doc Mortgage | Asset Based Lender




Commercial Asset Based Loans
& Private Equity Capital
for Commercial or Residential
Real Estate Properties!
Apply Now!

Stated Income Mortgages ,
No Doc Investment Home Loans , and other
Commercial Business Loans!
Apply Now!

 

Hard Money - Private Money - Orlando - Miami - Jacksonville - Tampa Bay - Hard Private Money Lenders - Real Estate Loans - Investor Financing - Hard Equity - Hard Asset Lender

Mark Battles VP of
Battles Capital Investments Inc.
Can Arrange Your Private
Hard Money Loans In Florida!


Visit: www.PrivateMoney.me
For More Information!



 


Looking for Traditional Financing?

   


This Domain Name "StatedMortgageLoans.com" Could Be 4-Sale - Check Now!

 

Peoples Bancorp Reports 29% Increase in Net Income
Posted on Tuesday November 25, 2014

AUBURN, Ind. -- Peoples Bancorp (OTCQB:PBNI) reported net income for the fiscal year ended September 30, 2014, was $3,404,323 versus the previous year's income of $2,626,795. Fiscal 2014 earnings per diluted ...

W. P. Carey Announces $45 Million of Investments by CPA:18 - Global
Posted on Tuesday November 25, 2014

NEW YORK, Nov. 25, 2014 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC), a real estate investment trust (REIT) specializing in corporate sale-leaseback financing , build-to-suit financing and the acquisition ...

PDL BioPharma Acquires a Portion of the University of Michigan's Royalty Interest in Genzyme's Cerdelga™ (eliglustat ...
Posted on Thursday November 06, 2014

INCLINE VILLAGE, Nev., Nov. 6, 2014 /PRNewswire/ -- PDL BioPharma ("PDL") (PDLI) announced today that it has acquired a portion of the University of Michigan's ("U-M") worldwide royalty interest in Cerdelga™ (eliglustat) for $65.6 million.  Cerdelga, an oral therapy for adult patients with Gaucher disease type 1, was developed by Genzyme, a Sanofi company.  Cerdelga was approved by the U.S ...

Great Lakes Reports Third Quarter Results
Posted on Wednesday November 05, 2014

Great Lakes Dredge & Dock Corporation , the largest provider of dredging services in the United States and a major provider of environmental and remediation servic

Brampton Brick Reports Results for the Third Quarter Ended September 30, 2014
Posted on Tuesday November 04, 2014

 






Home
::Privacy Policy ::Sitemap
© Battles Capital Investments Inc.



 


Today's Date: 2014-11-25